cTnI levels did not differ between the three conditions (Fig. 1B) and were always within normal limits, except for two Alzheimer’s disease cases where, however, cTnT levels were also elevated (15.2/29.2 and 89.2/105.7, respectively). This evidence concerns the gene TNNT2 and early-onset autosomal dominant Alzheimer disease.